Hospitalization costs of coronaviruses diseases in upper-middle-income countries: A systematic review.
César Ramos Rocha-FilhoJohnny Wallef Leite MartinsRosa Camila LucchettaGabriel Sodré RamalhoGiulia Fernandes Moça TrevisaniAline Pereira da RochaAna Carolina Pereira Nunes PintoFelipe Sebastião de Assis ReisLaura Jantsch FerlaPatrícia de Carvalho MastroianniLuci CorreaHumberto SaconatoVirgínia Fernandes Moça TrevisaniPublished in: PloS one (2022)
Our findings elucidate the importance of COVID-19 on health-economic outcomes. The marked heterogeneity among studies leaded to substantially different results and made challenging the comparison of data to estimate pooled results for single countries or regions. Further studies concerning cost estimates from standardized analysis may provide clearer data for a more substantial analysis. This may help care providers and policy makers to organize care for patients in the most efficient way.
Keyphrases
- healthcare
- sars cov
- public health
- mental health
- palliative care
- end stage renal disease
- coronavirus disease
- electronic health record
- newly diagnosed
- ejection fraction
- chronic kidney disease
- quality improvement
- big data
- randomized controlled trial
- physical activity
- prognostic factors
- risk assessment
- metabolic syndrome
- data analysis
- machine learning
- clinical trial
- single cell
- case control
- climate change
- patient reported
- glycemic control
- clinical evaluation